Avantor's NuSil Expands Partnership with Population Council for Three-Month Dapivirine Vaginal Ring to Advance HIV Prevention
核心洞察
Avantor (搜索)'s NuSil (搜索) brand has expanded its collaboration with the Population Council (搜索) to develop a next-generation three-month dapivirine vaginal ring for HIV (搜索) prevention in women.
The extended-duration ring requires only four replacements annually instead of 12, aiming to improve patient adherence, convenience, and lower annual treatment costs.
The Population Council (搜索) submitted the three-month ring for regulatory review by the European Medicines Agency (搜索) in November 2025, with additional approvals planned across sub-Saharan Africa.
Avantor (搜索)'s NuSil (搜索) brand has expanded its long-standing collaboration with the Population Council (搜索) to support the development of a next-generation three-month dapivirine vaginal ring for HIV (搜索) prevention, the company announced. Under the partnership, NuSil will supply its high-purity medical-grade silicones, which are critical to the device's drug delivery performance and mechanical reliability over the extended duration.
The expanded collaboration builds on NuSil (搜索)'s established relationship with the International Partnership for Microbicides, which was acquired by the Population Council (搜索) in 2022. NuSil previously supplied its high-purity silicones for the one-month dapivirine vaginal ring, a product that has since received regulatory approval in 12 countries across sub-Saharan Africa and is recommended for HIV (搜索) prevention in women aged 16 years and older, including those who are breastfeeding.
Advancing Toward a Three-Month Regimen
Leveraging the experience gained from the one-month ring program, the partners are now advancing a three-month version designed to require only four replacements annually instead of 12. The extended-duration device is expected to improve patient adherence and convenience while lowering annual treatment costs and expanding access to HIV (搜索) prevention, particularly in regions where women continue to face a disproportionately high burden of HIV infection.
NuSil (搜索)'s medical-grade silicones play a critical role in ensuring the ring's structural integrity, controlled drug release, and consistent mechanical performance throughout the three-month period. Clinical studies have shown that the three-month ring delivers higher levels of dapivirine than the monthly version, indicating the potential for improved efficacy and greater user acceptance.
Regulatory Pathway and Market Access
The Population Council (搜索) submitted the product for regulatory review by the European Medicines Agency (搜索) (EMA) in November 2025 and plans to pursue additional approvals across sub-Saharan Africa and other global markets following the EMA review. The successful commercialization of the three-month ring could create recurring demand for Avantor (搜索)'s specialized materials while enhancing its credibility as a trusted supplier for complex medical technologies.
From a market perspective, the global drug-device combination products market is projected to grow from $177.5 billion in 2026 to $251.9 billion by 2030, at a compound annual growth rate of 9% from 2025 to 2030, according to data from Grand View Research. The market is expected to benefit from continued technological advancements, rising demand for minimally invasive drug delivery devices, the growing prevalence of chronic diseases, and an expanding geriatric population.
Strategic Implications for Avantor (搜索)
Although the collaboration is unlikely to have a meaningful near-term financial impact, it supports Avantor (搜索)'s strategy of expanding customer relationships in the life sciences market and strengthens its positioning in innovative healthcare solutions with long-term growth potential. The partnership aligns with the company's strategy of expanding its presence in high-growth biopharma and medical technology markets, potentially opening doors to similar opportunities in the future.
Experience gained from this program may be transferable to other long-acting drug-delivery platforms, potentially creating additional partnerships with global health organizations. Shares of Avantor (搜索) surged nearly 7% following the announcement, though the company's stock has lost 1.4% in the year-to-date period. Avantor currently holds a market capitalization of $29.86 billion.